Study of the virulence of serotypes 4 and 9 of African horse sickness virus in IFNAR-/-, Balb/C and 129 Sv/Ev mice

被引:3
作者
de la Grandiere, Maria Ana [1 ]
Dal Pozzo, Fabiana [2 ]
Tignon, Marylene [3 ]
Zonta, William [1 ]
Thiry, Damien [1 ]
Mauroy, Axel [1 ]
Mathijs, Elisabeth [4 ]
Caij, Ann Brigitte [2 ,3 ]
Saegerman, Claude
Thiry, Etienne [1 ]
机构
[1] Univ Liege, Fac Vet Med, FARAH, B-4000 Liege, Belgium
[2] Univ Liege, Fac Vet Med, Res Unit Epidemiol & Risk Anal Appl Vet Sci UREA, B-4000 Liege, Belgium
[3] Operat Direct Viral Dis Vet & Agrochem Res Ctr, Unit Enzoot & Re Emerging Viral Dis, Brussels, Belgium
[4] Vet & Agrochem Res Ctr, Virol Platform Unit, Operat Direct Viral Dis, Brussels, Belgium
关键词
African horse sickness virus; Orbivirus; Mice; Virulence; PLASMACYTOID DENDRITIC CELLS; I INTERFERON; BLUETONGUE; TIME; RESPONSES; INFECTION; SYSTEM; LETHAL; ASSAY; RNA;
D O I
10.1016/j.vetmic.2014.10.006
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
African horse sickness virus (AHSV) is a double-stranded RNA virus which belongs to the family Reoviridae, genus Orbivinis. Recent studies have focused on the interferon-alp receptor knock-out mice (IFNAR(-/-)) as a small animal laboratory for the development of AHSV vaccines. The aim of this work was to study in vivo the virulence of two strains of AHSV and to compare the outcome of the infection of three mouse strains. To address this, AHSV serotypes 4 (AHSV-4) and 9 (AHSV-9) were inoculated subcutaneously (SC) and intranasally (IN) in two immunocompetent mouse strains (Balb/C and 129 Sv/Ev (129 WT)) as well as IFNAR(-/-) mice (on 129 Sv/Ev genetic background). In IFNAR(-/-) mice, fatality up to 50% was measured and significantly more clinical signs were observed in comparison with SC inoculated immunocompetent mice. The observed clinical signs were significantly more severe after AHSV-4 infection, in particular in immunocompetent mice inoculated by IN route. Considering RNAemia, significantly higher viral loads were measured following AHSV-4 infection. In the organs of 129 WT inoculated by IN route, significantly higher viral loads were detected after AHSV-4 infection. Together the results support a higher virulence for AHSV-4 compared to AHSV-9 and a higher clinical impact following infections in IN inoculated mice, at least in the investigated strains. The study also brought indirect evidences for type I IFN involvement in the control of AHSV infection. (C) 2014 Elsevier B.V. All Tights reserved.
引用
收藏
页码:322 / 332
页数:11
相关论文
共 35 条
  • [1] Real-time fluorogenic reverse transcription polymerase chain reaction assay for detection of African horse sickness virus
    Aguero, Montserrat
    Gomez-Tejedor, Concepcion
    Angeles Cubillo, Maria
    Rubio, Consuelo
    Romero, Esther
    Angel Jimenez-Clavero, Miguel
    [J]. JOURNAL OF VETERINARY DIAGNOSTIC INVESTIGATION, 2008, 20 (03) : 325 - 328
  • [2] 'Schmallenberg virus' - a novel orthobunyavirus emerging in Europe
    Beer, M.
    Conraths, F. J.
    Van der Poel, W. H. M.
    [J]. EPIDEMIOLOGY AND INFECTION, 2013, 141 (01) : 1 - 8
  • [3] Crimean-Congo hemorrhagic fever virus infection is lethal for adult type I interferon receptor-knockout mice
    Bereczky, Sandor
    Lindegren, Gunnel
    Karlberg, Helen
    Akerstrom, Sara
    Klingstrom, Jonas
    Mirazimi, Ali
    [J]. JOURNAL OF GENERAL VIROLOGY, 2010, 91 : 1473 - 1477
  • [4] Role of early cytokines, including alpha and beta interferons (IFN-α/β), in innate and adaptive immune responses to viral infections
    Biron, CA
    [J]. SEMINARS IN IMMUNOLOGY, 1998, 10 (05) : 383 - 390
  • [5] Serological survey of African horse sickness in selected districts of Jimma zone, Southwestern Ethiopia
    Bitew, Molalegne
    Andargie, Ashenafi
    Bekele, Mihreteab
    Jenberie, Shiferaw
    Ayelet, Gelagay
    Gelaye, Esayas
    [J]. TROPICAL ANIMAL HEALTH AND PRODUCTION, 2011, 43 (08) : 1543 - 1547
  • [6] Vaccination of mice with a modified Vaccinia Ankara (MVA) virus expressing the African horse sickness virus (AHSV) capsid protein VP2 induces virus neutralising antibodies that confer protection against AHSV upon passive immunisation
    Calvo-Pinilla, Eva
    de la Poza, Francisco
    Gubbins, Simon
    Mertens, Peter Paul Clement
    Ortego, Javier
    Castillo-Olivares, Javier
    [J]. VIRUS RESEARCH, 2014, 180 : 23 - 30
  • [7] A Modified Vaccinia Ankara Virus (MVA) Vaccine Expressing African Horse Sickness Virus (AHSV) VP2 Protects Against AHSV Challenge in an IFNAR -/- Mouse Model
    Castillo-Olivares, Javier
    Calvo-Pinilla, Eva
    Casanova, Isabel
    Bachanek-Bankowska, Katarzyna
    Chiam, Rachael
    Maan, Sushila
    Maria Nieto, Jose
    Ortego, Javier
    Mertens, Peter Paul Clement
    [J]. PLOS ONE, 2011, 6 (01):
  • [8] NS3 of Bluetongue Virus Interferes with the Induction of Type I Interferon
    Chauveau, Emilie
    Doceul, Virginie
    Lara, Estelle
    Breard, Emmanuel
    Sailleau, Corinne
    Vidalain, Pierre-Olivier
    Meurs, Eliane F.
    Dabo, Stephanie
    Schwartz-Cornil, Isabelle
    Zientara, Stephan
    Vitour, Damien
    [J]. JOURNAL OF VIROLOGY, 2013, 87 (14) : 8241 - 8246
  • [9] Ns1 Is a Key Protein in the Vaccine Composition to Protect Ifnar(-/-) Mice against Infection with Multiple Serotypes of African Horse Sickness Virus
    de la Poza, Francisco
    Calvo-Pinilla, Eva
    Lopez-Gil, Elena
    Marin-Lopez, Alejandro
    Mateos, Francisco
    Castillo-Olivares, Javier
    Lorenzo, Gema
    Ortego, Javier
    [J]. PLOS ONE, 2013, 8 (07):
  • [10] Plasmacytoid dendritic cells promote rotavirus-induced human and murine B cell responses
    Deal, Emily M.
    Lahl, Katharina
    Narvaez, Carlos F.
    Butcher, Eugene C.
    Greenberg, Harry B.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (06) : 2464 - 2474